Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s12272-018-01108-7.

Title:
Therapeutic implications of cancer epithelial-mesenchymal transition (EMT) | Archives of Pharmacal Research
Description:
The epithelial-mesenchymal transition (EMT) comprises an essential biological process involving cancer progression as well as initiation. While the EMT has been regarded as a phenotypic conversion from epithelial to mesenchymal cells, recent evidence indicates that it plays a critical role in stemness, metabolic reprogramming, immune evasion and therapeutic resistance of cancer cells. Interestingly, several transcriptional repressors including Snail (SNAI1), Slug (SNAI2) and the ZEB family constitute key players for EMT in cancer as well as in the developmental process. Note that the dynamic conversion between EMT and epithelial reversion (mesenchymal-epithelial transition, MET) occurs through variable intermediate-hybrid states rather than being a binary process. Given the close connection between oncogenic signaling and EMT repressors, the EMT has emerged as a therapeutic target or goal (in terms of MET reversion) in cancer therapy. Here we review the critical role of EMT in therapeutic resistance and the importance of EMT as a therapeutic target for human cancer.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

pubmed, cancer, article, google, scholar, cas, emt, cell, snail, transition, central, epithelialmesenchymal, kim, cells, signaling, tumor, phase, epithelial, therapeutic, development, kinase, tgfβ, zeb, clinical, expression, ecadherin, growth, biol, factor, receptor, res, patients, drug, study, progression, mesenchymal, breast, inhibitor, oncol, clin, pathway, lung, metastatic, advanced, lee, nat, resistance, slug, family, human,

Topics {✒️}

zinc-finger e-box binding tgf-beta-induced epithelial-mesenchymal transition blocks tgf-beta1-mediated epithelial mapk/erk-mediated zeb1 activity activate ras/raf/mek/erk tgf-β-mediated emt promotes multi-protein/transcriptional signaling pathways β-catenin/t-cell factor zinc-finger protein slug nf-κb signaling cascades article download pdf transforming growth factor-beta hypoxia-inducible factor 1α tgf-beta-induced epithelial emt-tfs emt-transcriptional factors growth factor-i-dependent links epithelial-mesenchymal transition axin2-mediated nuclear export emt-activating transcriptional factors translational/post-translational regulations mapk/egr-1-mediated upregulation e-cadherin repressor snail tgf-beta-induced activation wnt/beta-catenin signaling tgf-beta1-induced emt wnt/beta-catenin pathway epithelial-mesenchymal cell transition cancer epithelial-mesenchymal transition variable intermediate-hybrid states snail-expressing mdck cells wnt/β-catenin pathway regulate epithelial-mesenchymal transitions tgf-β signaling pathway tgf-β blocking antibody emt-activating transcription factors pre-planned interim analysis gsk-3-dependent phosphorylation motif targets tgf-β proteins increased transcriptional activity decreased e-cadherin expression promote emt-transcriptional factors double-negative feedback loop de jesus-acosta small-molecule alk5 inhibitors wnt/β-catenin/snail small-cell lung cancer disrupting axin-gsk3 interaction tgf-beta receptor function enhance tgf-β1 expression repressing e-cadherin expression

Questions {❓}

  • Yochum GS (2012) AXIN2: tumor suppressor, oncogene or both in colorectal cancer?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Therapeutic implications of cancer epithelial-mesenchymal transition (EMT)
         description:The epithelial-mesenchymal transition (EMT) comprises an essential biological process involving cancer progression as well as initiation. While the EMT has been regarded as a phenotypic conversion from epithelial to mesenchymal cells, recent evidence indicates that it plays a critical role in stemness, metabolic reprogramming, immune evasion and therapeutic resistance of cancer cells. Interestingly, several transcriptional repressors including Snail (SNAI1), Slug (SNAI2) and the ZEB family constitute key players for EMT in cancer as well as in the developmental process. Note that the dynamic conversion between EMT and epithelial reversion (mesenchymal-epithelial transition, MET) occurs through variable intermediate-hybrid states rather than being a binary process. Given the close connection between oncogenic signaling and EMT repressors, the EMT has emerged as a therapeutic target or goal (in terms of MET reversion) in cancer therapy. Here we review the critical role of EMT in therapeutic resistance and the importance of EMT as a therapeutic target for human cancer.
         datePublished:2019-01-16T00:00:00Z
         dateModified:2019-01-16T00:00:00Z
         pageStart:14
         pageEnd:24
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1007/s12272-018-01108-7
         keywords:
            Epithelial-mesenchymal transition
            EMT
            Therapeutic resistance
            Oncogenes
            Snail
            Wnt
            Pharmacy
            Pharmacology/Toxicology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12272-018-01108-7/MediaObjects/12272_2018_1108_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12272-018-01108-7/MediaObjects/12272_2018_1108_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12272-018-01108-7/MediaObjects/12272_2018_1108_Fig3_HTML.png
         isPartOf:
            name:Archives of Pharmacal Research
            issn:
               1976-3786
               0253-6269
            volumeNumber:42
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Pharmaceutical Society of Korea
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Eunae Sandra Cho
               affiliation:
                     name:Yonsei University College of Dentistry
                     address:
                        name:Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Republic of Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hee Eun Kang
               affiliation:
                     name:Yonsei University College of Dentistry
                     address:
                        name:Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Republic of Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Nam Hee Kim
               affiliation:
                     name:Yonsei University College of Dentistry
                     address:
                        name:Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Republic of Korea
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Jong In Yook
               url:http://orcid.org/0000-0002-7318-6112
               affiliation:
                     name:Yonsei University College of Dentistry
                     address:
                        name:Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Republic of Korea
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Therapeutic implications of cancer epithelial-mesenchymal transition (EMT)
      description:The epithelial-mesenchymal transition (EMT) comprises an essential biological process involving cancer progression as well as initiation. While the EMT has been regarded as a phenotypic conversion from epithelial to mesenchymal cells, recent evidence indicates that it plays a critical role in stemness, metabolic reprogramming, immune evasion and therapeutic resistance of cancer cells. Interestingly, several transcriptional repressors including Snail (SNAI1), Slug (SNAI2) and the ZEB family constitute key players for EMT in cancer as well as in the developmental process. Note that the dynamic conversion between EMT and epithelial reversion (mesenchymal-epithelial transition, MET) occurs through variable intermediate-hybrid states rather than being a binary process. Given the close connection between oncogenic signaling and EMT repressors, the EMT has emerged as a therapeutic target or goal (in terms of MET reversion) in cancer therapy. Here we review the critical role of EMT in therapeutic resistance and the importance of EMT as a therapeutic target for human cancer.
      datePublished:2019-01-16T00:00:00Z
      dateModified:2019-01-16T00:00:00Z
      pageStart:14
      pageEnd:24
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1007/s12272-018-01108-7
      keywords:
         Epithelial-mesenchymal transition
         EMT
         Therapeutic resistance
         Oncogenes
         Snail
         Wnt
         Pharmacy
         Pharmacology/Toxicology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12272-018-01108-7/MediaObjects/12272_2018_1108_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12272-018-01108-7/MediaObjects/12272_2018_1108_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12272-018-01108-7/MediaObjects/12272_2018_1108_Fig3_HTML.png
      isPartOf:
         name:Archives of Pharmacal Research
         issn:
            1976-3786
            0253-6269
         volumeNumber:42
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Pharmaceutical Society of Korea
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Eunae Sandra Cho
            affiliation:
                  name:Yonsei University College of Dentistry
                  address:
                     name:Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Republic of Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hee Eun Kang
            affiliation:
                  name:Yonsei University College of Dentistry
                  address:
                     name:Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Republic of Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Nam Hee Kim
            affiliation:
                  name:Yonsei University College of Dentistry
                  address:
                     name:Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Republic of Korea
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Jong In Yook
            url:http://orcid.org/0000-0002-7318-6112
            affiliation:
                  name:Yonsei University College of Dentistry
                  address:
                     name:Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Republic of Korea
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Archives of Pharmacal Research
      issn:
         1976-3786
         0253-6269
      volumeNumber:42
Organization:
      name:Pharmaceutical Society of Korea
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Yonsei University College of Dentistry
      address:
         name:Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Republic of Korea
         type:PostalAddress
      name:Yonsei University College of Dentistry
      address:
         name:Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Republic of Korea
         type:PostalAddress
      name:Yonsei University College of Dentistry
      address:
         name:Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Republic of Korea
         type:PostalAddress
      name:Yonsei University College of Dentistry
      address:
         name:Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Republic of Korea
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Eunae Sandra Cho
      affiliation:
            name:Yonsei University College of Dentistry
            address:
               name:Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Republic of Korea
               type:PostalAddress
            type:Organization
      name:Hee Eun Kang
      affiliation:
            name:Yonsei University College of Dentistry
            address:
               name:Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Republic of Korea
               type:PostalAddress
            type:Organization
      name:Nam Hee Kim
      affiliation:
            name:Yonsei University College of Dentistry
            address:
               name:Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Republic of Korea
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Jong In Yook
      url:http://orcid.org/0000-0002-7318-6112
      affiliation:
            name:Yonsei University College of Dentistry
            address:
               name:Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Republic of Korea
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Republic of Korea
      name:Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Republic of Korea
      name:Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Republic of Korea
      name:Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, Republic of Korea

External Links {🔗}(410)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.85s.